longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

RenovoRx

RNXT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • RNXT: Strong commercial growth and clinical data position RenovoCath for major oncology market impact

    Quartr·Sep 14 at 05:12 PM
    RNXT+1.80%
  • Niche Markets in Focus: Biotech Milestones and Gold Mining Gains Highlight Unconventional Equities

    Global Report·Sep 9 at 10:13 AM
    CELZ-6.47%RNXT+1.80%
  • 6 Biotech Stocks To Watch Ahead Of Key Catalysts: RenovoRx, Eupraxia, Connect Bio, Kardigan & More

    rttnews·Sep 3 at 03:23 AM
    EPRX-0.69%RNXT+1.80%
  • RenovoRx to present at H.C. Wainwright Global Investment Conference

    PUBT·Sep 2 at 03:16 AM
    RNXT+1.80%
  • The Uncategorized Long Tail: Structural Blind Spots in the Market

    Global Report·Sep 1 at 11:33 AM
    VITL-8.01%FJET-1.52%
  • Unclassified Micro-Signals Emerge Across Fringe Market Sectors

    Global Report·Sep 1 at 09:19 AM
    - U.S. fringe sectors are revealing micro-level divergence in capital flows and business progress as markets await key economic data. - Aerospace and cybersecurity firms like Loar Holdings and Check Point reported robust 2026 Q2 revenue growth, while commodity and biotech enterprises advanced through mergers and commercial milestones. - Conversely, electric vehicle and alternative audio companies faced transformation pressures and compliance risks, and space defense contractors encountered regulatory setbacks.
    YSS+1.54%CHKP+2.15%
  • Biotech Stocks At 52-Week Highs - RNXT +15%, EOLS, CRNX, APGE

    rttnews·Sep 1 at 07:46 AM
    EOLS+3.25%RNXT+1.80%
  • Biotech Stocks At 52-Week Highs - RNXT +12%, BLSM, RVTY, ATRC, BFRI

    rttnews·Aug 31 at 09:03 AM
    RNXT+1.80%ATRC+0.87%
  • RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Up 137.8% in August

    Market Beat·Aug 28 at 06:20 PM
    RNXT+1.80%
  • RenovoRx highlights Phase III TIGeR-PaC sub-study showing 51% tumor-site gemcitabine extraction with TAMP delivery

    PUBT·Aug 25 at 12:31 PM
    RNXT+1.80%
  • RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

    Unusual Whales·Aug 21 at 12:31 PM
    RNXT+1.80%